# Optical Coherence Tomography and Optical Coherence Tomography–Angiography Chronic Changes in End-Stage Renal Disease: A Systematic Review

**Authors:** Ioana-Madalina Bilha, Stefana Catalina Bilha, Nada Akad, Adrian Covic, Daniel-Constantin Branisteanu, Calina Anda Sandu, Vlad Constantin Donica, Camelia Margareta Bogdanici, Simona-Eliza Giusca, Irina Draga Caruntu

PMC · DOI: 10.3390/diagnostics16030459 · 2026-02-02

## TL;DR

This paper reviews how retinal imaging can detect chronic microvascular changes in patients with end-stage renal disease, suggesting it could help assess systemic vascular health.

## Contribution

The study systematically compiles chronic retinal and choroidal changes in ESRD using OCT and OCTA, highlighting their potential as biomarkers for systemic vascular dysfunction.

## Key findings

- Chronic retinal nerve fiber and ganglion cell layer thinning is consistently observed in ESRD patients.
- Reduced macular and peripapillary vascular densities correlate with systemic microvascular burden.
- Enlarged foveal avascular zones and decreased choroidal thickness are linked to disease severity.

## Abstract

Background/Objectives: End-stage renal disease (ESRD) is characterized by profound and progressive microvascular dysfunction that contributes significantly to systemic morbidity. Because the retinal and renal microcirculations share structural and physiological similarities, optical coherence tomography (OCT) and OCT angiography (OCTA) have emerged as promising tools for detecting ocular microvascular changes that may parallel systemic vascular injury. This systematic review aimed to consolidate evidence on chronic retinal and choroidal alterations in ESRD as assessed by OCT and OCTA. Methods: A systematic search of PubMed/MEDLINE (inception–June 2025) was performed using combinations of terms related to OCT, OCTA, ESRD, and hemodialysis. After removing duplicates and screening titles, abstracts, and full texts, we included clinical studies involving adults with ESRD or undergoing dialysis that reported chronic or baseline OCT/OCTA findings. Non-English publications, editorials, conference abstracts, case reports, and studies limited to acute pre-/post-dialysis changes were excluded. Seventeen studies met eligibility criteria. Acute findings were summarized narratively only when no chronic data existed for a specific parameter but were not incorporated into the primary synthesis. Results: Across eligible studies, chronic structural and perfusion abnormalities were consistently reported, including thinning of the retinal nerve fiber and ganglion cell layers, reduced macular and peripapillary vascular densities, enlarged foveal avascular zones, and decreased choroidal thickness. These alterations aligned with markers of disease severity and systemic microvascular burden. Conclusions: Retinal imaging reveals reproducible chronic microvascular changes in ESRD and may serve as an accessible adjunct for systemic vascular assessment. We highlight the potential significance of retinal vascular screening in this population and the need for more standardized imaging protocols to support the effective integration of retinal biomarkers into CKD diagnostic and monitoring strategies.

## Linked entities

- **Diseases:** end-stage renal disease (MONDO:0004375), ESRD (MONDO:0004375)

## Full-text entities

- **Diseases:** perfusion (MESH:D001480), CKD (MESH:D012080), vascular injury (MESH:D057772), ESRD (MESH:D007676), microvascular dysfunction (MESH:D017566)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12896568/full.md

---
Source: https://tomesphere.com/paper/PMC12896568